Inclusion Bodies and Refolding: Turning Insoluble Protein Into the Right Shape
The step matters because everything downstream depends on it. Inclusion bodies are described as key intermediates for protein production, and their quality affects both the refolding yield and the further purification work that follows [8]. A poor inclusion body is not a setback you can chromatograph your way out of later.
What an inclusion body actually is
The older picture of a dead lump of denatured protein has been revised. Functional and structural studies have shown that inclusion bodies are not dead-end aggregates but undergo dynamic changes inside the cell, including aggregation, refunctionalisation of the protein, and proteolysis [8]. They mostly contain only minor impurities and are relatively homogeneous [8]. Work on the conformation of aggregated proteins and on the biology of inclusion bodies in recombinant bacteria has yielded insights into protein folding and quality, and has also shown that soluble recombinant protein species carry an unexpected functional and structural complexity of their own [7].
Crucially for the recovery route, protein molecules inside inclusion body aggregates have a native-like structure [1]. That single observation underpins the mild solubilisation approach described below.
Aggregates differ from protein to protein
Inclusion bodies are not interchangeable. A study that expressed recombinant human growth hormone (hGH) and asparaginase as inclusion bodies in E. coli and followed the kinetics of aggregate formation found markedly different behaviour between the two [3]. Asparaginase inclusion bodies were smaller — around 200 nm — and the aggregate size did not increase with induction time [3]. The hGH inclusion bodies seeded and grew sequentially, were kinetically stable, and grew from 200 to 800 nm as induction continued [3].
Those physical differences translated directly into how hard the material was to open up. The hGH inclusion bodies showed higher resistance to denaturants and to proteinase K degradation than the asparaginase ones [3]. Asparaginase inclusion bodies were completely solubilised at 2–3 M urea and could be refolded into active protein; hGH inclusion bodies required 7 M urea for complete solubilisation [3]. Both bound amyloid-specific dyes, and binding was more prominent for hGH despite its low β-sheet content [3]. The arrangement of protein molecules at the surface and in the core of the inclusion bodies was similar [3]. For hGH, hydrophobic interactions between partially folded amphiphilic and hydrophobic alpha-helices were identified as one of the main determinants of inclusion body formation [3]. The conclusion drawn is general: the aggregation behaviour of the protein molecules decides the nature and properties of the inclusion bodies [3].
The practical reading is that the denaturant concentration needed is a property of the specific product and its aggregation route, not a standard recipe to be copied across molecules.
Fragments co-aggregate with the full-length product
Inclusion bodies can carry truncated product. Two-dimensional polyacrylamide gel electrophoresis of inclusion bodies of Saccharomyces cerevisiae alpha-glucosidase, overproduced in E. coli, showed a large amount of at least 12 different major product fragments [8]. MALDI-ToF mass spectrometry identified these as containing either the N- or the C-terminus of the protein, indicating that the inclusion bodies were at least partly created by proteolytic action [8].
What is striking is how stubborn that pattern proved. Knocking out the major proteases ClpP, Lon, OmpT and FtsH did not change the fragment pattern or the inclusion body composition [8]. Nor was inclusion body quality influenced by sampling time, cultivation medium (complex or mineral salt), production strategy (shake flask or fed-batch fermentation), promoter strength (T5-lac or T7), strain background (K-12 or BL21), or the addition of protease inhibitors during inclusion body preparation [8]. The authors concluded that alpha-glucosidase is fragmented before aggregation — not by the common major proteases acting on the inclusion bodies, and not during downstream preparation — and that fragments co-aggregate with full-length product during inclusion body formation [8].
For a process engineer that is a warning about where to look. If truncated species appear in the refolded pool, upstream process knobs may not move them, and the clearance burden falls on purification.
Isolation: getting the aggregate out cleanly
Current protocols for isolating inclusion bodies from E. coli usually recover between 95% and 99% of the protein, but in practice this can still leave extensive bacterial cell contamination [6]. Using an appropriate combination of chemical and mechanical cell disruption, one group established a procedure that recovered inclusion bodies with undetectable viable cell contamination — below 10⁻¹ cfu/ml — while keeping the particulate organisation of the aggregates in terms of size and protein folding features [6]. The point for recovery work is that disruption strategy affects not only purity but whether the aggregate's structure survives intact.
Solubilisation and refolding
Obtaining bioactive protein from inclusion bodies is labour intensive, and recombinant protein yields are often low [1]. A review of the field focuses on optimising the individual steps — in particular solubilisation of the inclusion bodies and refolding of the solubilised protein [1]. Mild solubilisation methods are built on the finding that protein in the aggregate already has native-like structure: these methods dissolve the aggregate while preserving that structure, and the subsequent refolding and purification give high recovery of bioactive protein [1].
A second approach reported high efficiency by changing the sequence of operations rather than the reagents. A "two-step-denaturing and refolding" (2DR) method uses two denaturation steps and one refolding step [5]. Its authors first compared it with a conventional one-denaturation, one-refolding procedure on three proteins with different folding properties, and found the refolded proteins active in in vitro tests and a bioassay [5]. They then applied the method to 88 proteins from human and other organisms, all expressed as inclusion bodies: about 76% were refolded, with an average of more than 75% yield of soluble protein [5]. The method is described as simple, highly efficient and generally applicable for both research and industrial purposes [5].
Avoiding the aggregate in the first place
Inclusion body formation is a frequently encountered obstacle to producing soluble, functional recombinant protein, and several strategies exist to prevent it: adjusting growth conditions, engineering the host strain, altering the expression vector, and modifying the protein of interest [2]. The mechanisms leading to inclusion body formation are not completely understood, although empirical data have been used to try to predict the aggregation propensity of particular proteins [4]. Inclusion bodies also have potential advantages of their own [2], and being fully biocompatible they have been characterised as nanoparticulate inert materials [6].
What to take from it
Three things carry over when you are choosing or auditing a process. First, ask what the inclusion body is like for your specific molecule — size, growth with induction time, denaturant resistance — because those properties, not a generic protocol, set the solubilisation condition [3]. Second, ask whether solubilisation is harsher than it needs to be: if native-like structure is already present in the aggregate, a mild condition can preserve it and lift refolding recovery [1]. A supplier who can describe the aggregate, the disruption method and the solubilisation condition separately is describing a process they control.
References
- Singh A, Upadhyay V, Upadhyay AK, Singh SM, Panda AK. Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process — Microbial cell factories, 2015-03-25.
- Bhatwa A, Wang W, Hassan YI, Abraham N, Li XZ, Zhou T. Challenges Associated With the Formation of Recombinant Protein Inclusion Bodies in Escherichia coli and Strategies to Address Them for Industrial Applications — Frontiers in bioengineering and biotechnology, 2021-02-10.
- Upadhyay AK, Murmu A, Singh A, Panda AK. Kinetics of inclusion body formation and its correlation with the characteristics of protein aggregates in Escherichia coli — PloS one, 2012-03-29.
- Ramón A, Señorale-Pose M, Marín M. Inclusion bodies: not that bad… — Frontiers in microbiology, 2014-02-14.
- Yang Z, Zhang L, Zhang Y, Zhang T, Feng Y, Lu X, Lan W, Wang J, Wu H, Cao C, Wang X. Highly efficient production of soluble proteins from insoluble inclusion bodies by a two-step-denaturing and refolding method — PloS one, 2011-07-29.
- Rodríguez-Carmona E, Cano-Garrido O, Seras-Franzoso J, Villaverde A, García-Fruitós E. Isolation of cell-free bacterial inclusion bodies — Microbial cell factories, 2010-09-17.
- Martínez-Alonso M, González-Montalbán N, García-Fruitós E, Villaverde A. Learning about protein solubility from bacterial inclusion bodies — Microbial cell factories, 2009-01-08.
- Jürgen B, Breitenstein A, Urlacher V, Büttner K, Lin H, Hecker M, Schweder T, Neubauer P. Quality control of inclusion bodies in Escherichia coli — Microbial cell factories, 2010-05-28.

